Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMA | AZN | AMGN | GILD | GSK |
| Company | Adma Biologics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.52 | 204.20 | 351.70 | 140.96 | 59.28 |
| High | 10.72 | 204.39 | 352.60 | 140.96 | 59.28 |
| Low | 10.51 | 202.01 | 347.45 | 138.36 | 58.69 |
| Latest | 10.66 | 202.33 | 347.47 | 138.93 | 58.53 |
| Change | +0.17 | -2.05 | -3.48 | -1.52 | -0.65 |
| % Change | +1.62% | -1.00% | -0.99% | -1.08% | -1.10% |
| Volume | 607,284 | 347,647 | 149,230 | 428,144 | 402,439 |
| 20-Day Average Volume | 10,014,611 | 1,840,144 | 2,683,573 | 5,896,842 | 4,103,812 |
| Previous Close | 10.49 | 204.38 | 350.95 | 140.45 | 59.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.61 | 195.58 | 349.69 | 139.02 | 55.44 |
| 20-Day Raw Stochastic | 38.74% | 82.26% | 53.35% | 53.10% | 90.78% |
| 20-Day Relative Strength | 38.91 | 57.02 | 45.80 | 47.39 | 61.85 |
| Weighted Alpha | -39.92 | +49.10 | +24.63 | +32.13 | +65.80 |
| Today's Opinion | 100% Sell | 88% Buy | 40% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 56% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 88% Sell | 56% Buy | 88% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.83% since 04/08/26 | -0.68% since 04/08/26 | -0.31% since 04/08/26 | -1.69% since 04/08/26 | +2.54% since 04/08/26 |
| Low | 9.60 on 04/09/26 | 200.70 on 04/13/26 | 345.41 on 04/14/26 | 137.02 on 04/13/26 | 57.01 on 04/09/26 |
| High | 10.76 on 04/14/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.57 on 04/14/26 |
| 1-Month | |||||
| %Chg | -30.04% since 03/13/26 | +6.84% since 03/13/26 | -4.77% since 03/13/26 | -4.03% since 03/13/26 | +10.19% since 03/13/26 |
| Low | 7.21 on 03/26/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 51.54 on 03/20/26 |
| High | 16.39 on 03/17/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 59.57 on 04/14/26 |
| 3-Month | |||||
| %Chg | -39.43% since 01/15/26 | +7.93% since 01/15/26 | +5.67% since 01/15/26 | +14.75% since 01/15/26 | +19.77% since 01/15/26 |
| Low | 7.21 on 03/26/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.10 on 01/16/26 | 47.62 on 01/20/26 |
| High | 18.00 on 02/03/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -29.76% since 10/15/25 | +19.58% since 10/15/25 | +17.29% since 10/15/25 | +17.62% since 10/15/25 | +34.38% since 10/15/25 |
| Low | 7.21 on 03/26/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.85 on 10/24/25 |
| High | 20.46 on 12/12/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,498,288 | 316,974,592 | 189,402,464 | 174,329,632 | 120,222,808 |
| Shares Outstanding, K | 238,159 | 1,550,908 | 539,685 | 1,241,222 | 2,031,477 |
| Annual Sales | 510,170,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | 146,930,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 139,160,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,424,970,000 |
| Last Quarter Net Income | 49,380,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 851,670,000 |
| 60-Month Beta | 0.82 | 0.35 | 0.47 | 0.39 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.20 on 02/25/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.68 on 02/04/26 |
| Latest Earnings Date | 05/06/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.470 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 15.97 | 22.08 | 16.01 | 17.06 | 13.04 |